Growth of uninfected infants exposed to antiretrovirals born to HIV-infected woman;Exposición a antirretrovirales y crecimiento en una cohorte de niños no infectados, hijos de madre con VIH positivo

Anales de Pediatria

Volumn 71, Issue 4, 2009, Pages 299-309

  Fernandez Ibieta M ^a   Bellon Cano J M ^b   Ramos Amador, J T ^a   Gonzalez Tome M I ^c   Guillen Martin S ^a   Navarro Gomez M ^b   De Jose M I ^d   Beceiro, J ^e   Iglesias, E ^a   Prieto, L ^a   Santos, M J ^f   Martinez Guardia N ^f   Roa, M A ^g   Regidor, J ^h  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^f HOSPITAL SEVERO OCHOA   (Spain)

^g HOSPITAL DE MÓSTOLES   (Spain)

^h HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Antiretroviral therapy; Growth; HIV; Pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; ANEMIA; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; DRUG EXPOSURE; FEMALE; HEAD CIRCUMFERENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MATERNAL SMOKING; MULTICENTER STUDY; PREGNANCY; PRESCHOOL CHILD; PUBLIC HOSPITAL; RISK FACTOR; SPAIN;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY HEIGHT; BODY WEIGHT; CEPHALOMETRY; FEMALE; GROWTH; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 70349622497     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2009.06.019     Document Type: Article

References (23)

1. C. Thorne, D. Patel, S. Fiore, C. Peckham, and M.L. Newell Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy Clin Infect Dis 40 2005 458 465
2. J. Warszawski, R. Tubiana, J. Le Chedenac, S. Blanche, J.P. Teglas, and C. Dollfus Mother-to-child HIV transmission despite antiretroviral therapy in the ANS French perinatal cohort AIDS 22 2008 289 299
3. J. Move, K.C. Rich, L.H. Kalish, A.R. Sheon, C. Díaz, and E.R. Cooper Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. WITS J Pediatr 128 1996 58 69
4. S. Guillén, J.T. Ramos, R. Resino, J.M. Bellón, and M.A. Muñoz Impact on weight and height with the use of HAART in HIV-infected children Pediatr Infect Dis J 26 2007 334 338
5. Schulte J, Dominguez K, Sucalak T, Bohannon B, Fowler MG. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric spectrum of HIV disease, 1989-2004 Pediatrics [en línea] [citado 20 Ene 2009]. Disponible en: URL: www.Pediatrics.org/cgi/doi/10.1542/peds.2006-1123
6. C. Hankin, C. Thorne, C. Peckham, and M.L. Newell Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women J Acquir Inmun Defic Syndr 32 2003 380 387
7. C. Thorne, D. Patel, and M.L. Newell Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe AIDS 19 2004 2337 2339
8. R. Sperling, D.E. Shapiro, G.D. McSherry, P. Britto, B.E. Cunningham, and M. Culnane Safey of the maternal-infant zidovudine regimen utilized in the pediatric AIDS Clinical Trial group 076 Study AIDS 12 1998 1805 1813
9. M. Culnane, M.G. Fowler, S. Lee, G. McSherry, M. Brady, and K. O'Donnel Lack of long-term effects of in-utero exposure to zidovudine among uninfected children born to HIV-infected women JAMA 281 1999 151 157
10. L.M. Mofenson, and P. Munderi Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants J Acquir Inmun Defic Syndr 30 2002 200 215
11. C. Hankin, C. Thorne, and M.L. Newell Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr 40 2005 364 370
12. C. Agostini, G.V. Zuccotti, M. Giovannini, S. Decarlis, M.L. Gianni, and E. Piacentini et al. Growth in the first two years of uninfected children born to HIV-1 seropositive mothers Arch Dis Child 79 1998 175 178
13. N. Briand, S. Le Coeur, P. Traisathit, V. Karnchanamayul, R. Hansudewechakul, and C. Ngampiyasakul Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission Pediatr Infect Dis J 25 2006 325 332
14. A. Ross, G.M. Raab, J. Mok, S. Gilkison, B. Hamilton, and F. Johnstone Maternal HIV infection, drug use, and growth of uninfected children in their first 3 years Arch Dis Child 73 1995 490 495
15. C. Townsend, M. Cortina-Borja, C. Peckham, and P. Tookey Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland AIDS 21 2007 1019 1026
16. M. Makasa, L. Kasonha, M. Chisenga, M. Sinkala, C. Chintu, and A. Tomkins et al. Early growth of infants of HIV-infected and uninfected Zambian women Trop Med Internat H 12 2007 594 602
17. T.E. Taha, G.A. Dallabetta, J.K. Canner, J.D. Chiphangwi, G. Liomba, and D.R. Hoover et al. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi Int J Epidemiol 24 1995 1022 1029
18. B. Sherry, J. Embree, M. Zuguo, O. Jackoniah, N. Dinya-Achola, and S. Njenga et al. Sociodemographic characteristics, car, feeding practices and growth of cohorts of children born to HIV-1 seropositive and seronegative mothers in Nairobi, Kenya Trop Med Internat H 5 2000 678 686
19. R. Bailey, K. Munkolenkole, M. Nsuami, P. Nieburg, and M. St. Louis Growth of children according to maternal and Child HIV, immunological and disease characteristics: A prospective cohort study in Kinshasa, Democratic Republic of Congo Internat J Epidem 28 1999 532 540
20. P. Lepage, P. Msellati, D. Hitimana, A. Bazubagira, C. Van Goethem, and A. Simonon et al. Growth of human immunodeficiency type 1-infected and uninfected children: A prospective cohort study in Kigaly, Rwanda, 1988 to 1993 Pediat Infect Dis J 1996 15479 15485
21. M.L. Newell, M. Cortina-Borja, C. Thorne, and C. Peckham Height, weight and growth in children born to mothers with HIV-1 infection in Europe Pediatrics 111 2003 e52 e60
22. M. Paul, C. Chantry, J. Read, M. Frederick, M. Lu, and J. Pitt Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women Pediatr Infect Dis J 24 2005 46 56
23. J.M. Saavedar, R.A. Henderson, J.A. Perman, N. Hutton, R.A. Livingston, and R.H. Yolken Longitudinal assessment of growth in children born to mothers with human immunodeficiency virus infection Arch Peditr Adolesc Med 149 1995 497 502